Answers are grounded in this paper and cite their sources.
Model demonstrates variations in tissue density affect tumor growth in lung cancer, highlighting metabolic pathways.
Serial low-dose computed tomography (LDCT) scans in patients who are diagnosed with lung cancer during screening offer a history of the densities of tumors and the tissues that surround them during carcinogenesis and cancer progression. We built a CT-scan resolution computational model to explore how variations in lung tissue density impact tumor growth and evolution in non-small cell lung cancer (NSCLC). Our findings indicate that tumors spread more rapidly through denser tissues when they upregulate glycolytic pathways and acid production, whilst tumors spread more rapidly through sparser tissues when they upregulate angiogenesis. We used data and images from the National Lung Screening Trial to calibrate our model for untreated lung cancer growth in patients and corroborated our findings in low-density environments.
No takes yet. Share an insight, caveat, or question.
Bravo et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: